Chemical Compound
2-PIPERIDINECARBOXYLIC ACID, 1-FORMYL-, 3-HYDROXY-1-(2-(4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHENYL)-12-METHOXY-2,8,10-TRIMETHYL-5-OXO-6-(2-PROPENYL)-12-(TETRAHYDRO-3-METHOXY-5-METHYL-6-OXO-2H-PYRAN-2-YL)-7-DODECENYL ESTER, (2R-(2.ALPHA.(1S*((E(1R*,3R*,4R*)),(S*)),2R*,3S*,6R*,7E,10S*,12S*),3.BETA.,5.BETA.))-
CAS Registry Number
143210-33-7
Primary record
2-PIPERIDINECARBOXYLIC ACID, 1-FORMYL-, 3-HYDROXY-1-(2-(4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHENYL)-12-METHOXY-2,8,10-TRIMETHYL-5-OXO-6-(2-PROPENYL)-12-(TETRAHYDRO-3-METHOXY-5-METHYL-6-OXO-2H-PYRAN-2-YL)-7-DODECENYL ESTER, (2R-(2.ALPHA.(1S*((E(1R*,3R*,4R*)),(S*)),2R*,3S*,6R*,7E,10S*,12S*),3.BETA.,5.BETA.))-
- 库存
- 4,221 克
- 纯度
- 98.9 %
- CAS
- 143210-33-7
化合物标识与属性
- CAS
- 143210-33-7
- PubChem CID
- 101342455
- SMILES
- C[C@@H]1C[C@@H]([C@H](OC1=O)[C@H](C[C@@H](C)C/C(=C/[C@@H](CC=C)C(=O)C[C@@H]([C@@H](C)[C@@H](/C(=C/[C@@H]2CC[C@H]([C@@H](C2)OC)O)/C)OC(=O)[C@@H]3CCCCN3C=O)O)/C)OC)OC
- Canonical SMILES
- C=CC[C@H](/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]1OC(=O)[C@H](C)C[C@@H]1OC)C(=O)C[C@H](O)[C@@H](C)[C@H](OC(=O)[C@@H]1CCCCN1C=O)/C(C)=C/[C@@H]1CC[C@@H](O)[C@H](OC)C1
名称与同义词
- Tacrolimus EP Impurity H
- XB5YB7L8RD
- UNII-XB5YB7L8RD
- TACROLIMUS IMPURITY H
- BBF-05744
- 143210-33-7
- J2.024.002D
- TACROLIMUS MONOHYDRATE IMPURITY H [EP IMPURITY]
- (1E,3S,4R,5S,8R,9E,12S,14S)-5-Hydroxy-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-14-methoxy-14-((2R,3S,5R)-3-methoxy-5-methyl-6-oxooxan-2-yl)-2,4,10,12-tetramethyl-7-oxo-8-(prop-2-en-1-yl)tetradeca-1,9-dien-3-yl (2S)-1-formylpiperidine-2-carboxylate
- (1E,3S,4R,5S,8R,9E,12S,14S)-5-hydroxy-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-14-methoxy-14-[(2R,3S,5R)-3-methoxy-5-methyl-6-oxooxan-2-yl]-2,4,10,12-tetramethyl-7-oxo-8-(prop-2-en-1-yl)tetradeca-1,9-dien-3-yl (2S)-1-formylpiperidine-2-carboxylate
- (1E,3S,4R,5S,8R,9E,12S,14S)-8-allyl-5-hydroxy-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-14-methoxy-14-((2R,3S,5R)-3-methoxy-5-methyl-6-oxotetrahydro-2H-pyran-2-yl)-2,4,10,12-tetramethyl-7-oxotetradeca-1,9-dien-3-yl (S)-1-formylpiperidine-2-carboxylate
- (2R,4S,5R,6S,8S,10E,12R,15S,16R,17S,18E)-2,8,10,16,18-Pentamethyl-4,6-dimethoxy-5,15-dihydroxy-12-allyl-13-oxo-17-[[(2S)-1-formyl-2alpha-piperidinyl]carbonyloxy]-19-[(1R)-3beta-methoxy-4alpha-hydroxycyclohexane-1beta-yl]-10,18-nonadecadienoic acid 1,5-lactone
- (2S)-2-Piperidinecarboxylic acid,1-formyl-,(1S,2R,3S,6R,7E,10S,12S)-3-hydroxy-1-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-12-methoxy-2,8,10-trimethyl-5-oxo-6-(2-propen-1-yl)-12-[(2R,3S,5R)-tetrahydro-3-methoxy-5-methyl-6-oxo-2H-pyran-2-yl]-7-dodecen-1-yl ester
- 2-PIPERIDINECARBOXYLIC ACID, 1-FORMYL-, (1S,2R,3S,6R,7E,10S,12S)-3-HYDROXY-1-((1E)-2-((1R,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHENYL)-12-METHOXY-2,8,10-TRIMETHYL-5-OXO-6-(2-PROPEN-1-YL)-12-((2R,3S,5R)-TETRAHYDRO-3-METHOXY-5-METHYL-6-OXO-2H-PYRAN-2-YL)-7-DODECEN-1-YL ESTER, (2S)-
- 2-PIPERIDINECARBOXYLIC ACID, 1-FORMYL-, 3-HYDROXY-1-(2-(4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHENYL)-12-METHOXY-2,8,10-TRIMETHYL-5-OXO-6-(2-PROPENYL)-12-(TETRAHYDRO-3-METHOXY-5-METHYL-6-OXO-2H-PYRAN-2-YL)-7-DODECENYL ESTER, (2R-(2.ALPHA.(1S*((E(1R*,3R*,4R*)),(S*)),2R*,3S*,6R*,7E,10S*,12S*),3.BETA.,5.BETA.))-
- 2-Piperidinecarboxylicacid,1-formyl-,(1S,2R,3S,6R,7E,10S,12S)-3-hydroxy-1-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1Chemicalbook-methylethenyl]-12-methoxy-2,8,10-trimethyl-5-oxo-6-(2-propen-1-yl)-12-[(2R,3S,5R)-tetrahydro-3-methoxy-5-methyl-6-oxo-2H-pyra